Does thrombophilia testing help in the clinical management of patients?MIDDELDORP, Saskia; VAN HYLCKAMA VLIEG, Astrid.British journal of haematology. 2008, Vol 143, Num 3, pp 321-335, issn 0007-1048, 15 p.Article

The Risk of Deep Venous Thrombosis Associated With Injectable Depot-Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine DeviceVAN HYLCKAMA VLIEG, Astrid; HELMERHORST, Frans M; ROSENDAAL, Frits R et al.Arteriosclerosis, thrombosis, and vascular biology. 2010, Vol 30, Num 11, pp 2297-2300, issn 1079-5642, 4 p.Article

Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on riskFLINTERMAN, Linda E; VAN HYLCKAMA VLIEG, Astrid; ROSENDAAL, Frits R et al.British journal of haematology. 2010, Vol 149, Num 1, pp 118-123, issn 0007-1048, 6 p.Article

Communication of Biobanks' Research Results: What Do (Potential) Participants Want?MEULENKAMP, Tineke M; GEVERS, Sjef K; BOVENBERG, Jasper A et al.American journal of medical genetics. Part A. 2010, Vol 152, Num 10, pp 2482-2492, issn 1552-4825, 11 p.Article

Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosisDAHM, Anders; VAN HYLCKAMA VLIEG, Astrid; BENDZ, Bjorn et al.Blood. 2003, Vol 101, Num 11, pp 4387-4392, issn 0006-4971, 6 p.Article

Protein Z and protein Z-dependent protease inhibitor : Determinants of levels and risk of venous thrombosisAL-SHANQEETI, Ali; VAN HYLCKAMA VLIEG, Astrid; BERNTORP, Erik et al.Thrombosis and haemostasis. 2005, Vol 93, Num 3, pp 411-413, issn 0340-6245, 3 p.Article

Candidate gene approach in association studies: would the factor V Leiden mutation have been found by this approach?VAN HYLCKAMA VLIEG, Astrid; SANDKUIJ, Lodewijk A; ROSENDAAL, Frits R et al.European journal of human genetics. 2004, Vol 12, Num 6, pp 478-482, issn 1018-4813, 5 p.Article

Smoking, postmenopausal hormone therapy and the risk of venous thrombosis: a population-based, case―control studyBLONDON, Marc; WIGGINS, Kerri L; VAN HYLCKAMA VLIEG, Astrid et al.British journal of haematology. 2013, Vol 163, Num 3, pp 418-420, issn 0007-1048, 3 p.Article

Haplotypes of VKORC1, NQ01 and GGCX, their effect on activity levels of vitamin K-dependent coagulation factors, and the risk of venous thrombosisDE VISSER, Marieke C. H; ROSHANI, Sara; RUTTEN, Julie W et al.Thrombosis and haemostasis. 2011, Vol 106, Num 3, pp 563-565, issn 0340-6245, 3 p.Article

Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and womenTANS, Guido; VAN HYLCKAMA VLIEG, Astrid; THOMASSEN, M. Christella L. G. D et al.British journal of haematology. 2003, Vol 122, Num 3, pp 465-470, issn 0007-1048, 6 p.Article

Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosisVAN HYLCKAMA VLIEG, Astrid; KOMANASIN, Nantarat; ARIËNS, Robert A. S et al.British journal of haematology. 2002, Vol 119, Num 1, pp 169-175, issn 0007-1048Article

Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosisSMITH, Nicholas L; RICE, Kenneth M; DEHGHAN, Abbas et al.Blood. 2011, Vol 117, Num 22, pp 6007-6011, issn 0006-4971, 5 p.Article